BOOTHBAY FUND MANAGEMENT, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 118 filers reported holding TG THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$8,348,724
+3610.5%
336,100
+2744.4%
0.18%
+3560.0%
Q4 2021$225,000
-67.9%
11,816
-43.9%
0.01%
-73.7%
Q3 2021$701,000
-18.1%
21,069
-4.5%
0.02%
-29.6%
Q2 2021$856,000
+321.7%
22,068
+423.1%
0.03%
+237.5%
Q1 2021$203,000
-65.1%
4,219
-92.0%
0.01%
-84.3%
Q4 2019$582,000
+12.4%
52,426
-12.5%
0.05%
+8.5%
Q2 2019$518,000
+482.0%
59,934
+175.3%
0.05%
+261.5%
Q4 2018$89,000
-60.1%
21,772
-45.4%
0.01%
-40.9%
Q3 2018$223,00039,8650.02%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 10,451,241$157,186,66542.99%
M28 Capital Management LP 339,500$5,106,0805.77%
Ghost Tree Capital, LLC 1,100,000$16,544,0004.89%
Soleus Capital Management, L.P. 750,300$11,284,5121.17%
Parkman Healthcare Partners LLC 275,641$4,145,6410.90%
683 Capital Management, LLC 775,000$11,656,0000.87%
Leucadia National 5,100,110$76,705,6540.62%
Pier Capital, LLC 233,472$3,511,4190.53%
Harvest Investment Services, LLC 40,729$612,5640.47%
Artal Group S.A. 511,389$7,6910.46%
View complete list of TG THERAPEUTICS INC shareholders